Abingworth, an international life sciences investment group and part of global investment firm Carlyle, has appointed Joy Ghosh, PhD as managing director.
Ghosh will be based at the firm’s Boston office and will work with the transatlantic team to identify new investment opportunities and support existing investments in innovative private and public companies, including those focused on clinical co-development.
Ghosh has over 15 years’ experience in life science investing and portfolio company management and in corporate strategy and drug development. He joins from Eventide Asset Management where he was portfolio manager responsible for a portfolio of innovation-focused public and private healthcare and life science companies. Prior to Eventide, Ghosh was vice president at Bain Capital. He has completed 24 private investments during his time at both firms and held board roles on multiple companies.
Earlier in his career, Ghosh held senior roles in business development and corporate strategy at Biogen, and as a project team leader at Novartis Institutes for BioMedical Research (NIBR).
